Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Gando

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Shock (Augusta, Ga.)|May 23, 2008
The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunctionMineji Hayakawa, Atsushi Sawamura, Yuichiro Yanagida, et al.
American Journal of Hematology|August 23, 2006
First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patientsSatoshi Gando, Atsushi Sawamura, Mineji Hayakawa, et al.
Medicine|May 25, 2021
Intensive care unit model and in-hospital mortality among patients with severe sepsis and septic shock: A secondary analysis of a multicenter prospective observational studyIsao Nagata, Toshikazu Abe, Hiroshi Ogura, et al.
Inflammation|January 28, 2005
Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activationSatoshi Gando, Takashi Kameue, Naoyuki Matsuda, et al.
Critical Care Medicine|August 7, 2002
Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosisSatoshi Gando, Takashi Kameue, Yuji Morimoto, et al.
Digestive Diseases and Sciences|May 12, 2012
Synbiotic therapy reduces the pathological gram-negative rods caused by an increased acetic acid concentration in the gutMineji Hayakawa, Takashi Asahara, Toshiteru Ishitani, et al.
Thrombosis Research|February 23, 2012
A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsisMineji Hayakawa, Atsushi Sawamura, Satoshi Gando, et al.
Thrombosis Research|May 24, 2005
Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulationSatoshi Gando, Takashi Kameue, Naoyuki Matsuda, et al.
Thrombosis Research|October 7, 2006
An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgerySatoshi Gando, Takashi Kameue, Atsushi Sawamura, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 9, 2008
Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illnessAtsushi Sawamura, Satoshi Gando, Mineji Hayakawa, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Shock (Augusta, Ga.)|May 23, 2008
The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunctionMineji Hayakawa, Atsushi Sawamura, Yuichiro Yanagida, et al.
American Journal of Hematology|August 23, 2006
First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patientsSatoshi Gando, Atsushi Sawamura, Mineji Hayakawa, et al.
Medicine|May 25, 2021
Intensive care unit model and in-hospital mortality among patients with severe sepsis and septic shock: A secondary analysis of a multicenter prospective observational studyIsao Nagata, Toshikazu Abe, Hiroshi Ogura, et al.
Inflammation|January 28, 2005
Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activationSatoshi Gando, Takashi Kameue, Naoyuki Matsuda, et al.
Critical Care Medicine|August 7, 2002
Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosisSatoshi Gando, Takashi Kameue, Yuji Morimoto, et al.
Digestive Diseases and Sciences|May 12, 2012
Synbiotic therapy reduces the pathological gram-negative rods caused by an increased acetic acid concentration in the gutMineji Hayakawa, Takashi Asahara, Toshiteru Ishitani, et al.
Thrombosis Research|February 23, 2012
A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsisMineji Hayakawa, Atsushi Sawamura, Satoshi Gando, et al.
Thrombosis Research|May 24, 2005
Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulationSatoshi Gando, Takashi Kameue, Naoyuki Matsuda, et al.
Thrombosis Research|October 7, 2006
An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgerySatoshi Gando, Takashi Kameue, Atsushi Sawamura, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 9, 2008
Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illnessAtsushi Sawamura, Satoshi Gando, Mineji Hayakawa, et al.
Pageof 22